Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor–Positive Non‐Small Cell Lung Cancer
Our data may help visualize future prospects and determine the timing of osimertinib initiation. New treatment strategies need to be developed for patients with bone/CNS metastasis at the first recurrence.
Authors
- Michitoshi Yabe (ORCID: https://orcid.org/0000-0002-8048-7108)
- Ryo Ko (ORCID: https://orcid.org/0000-0002-2551-3529)
- Akira Ono (ORCID: https://orcid.org/0000-0001-5705-9423)
- Motoki Sekikawa (ORCID: https://orcid.org/0009-0005-5637-5199)
- Toshiaki Takahashi (ORCID: https://orcid.org/0000-0002-8188-2505)
- Tateaki Naito (ORCID: https://orcid.org/0000-0003-4047-2929)
- Yasuhisa Ohde (ORCID: https://orcid.org/0000-0002-1664-2628)
- Hirotsugu Kenmotsu (ORCID: https://orcid.org/0000-0003-0590-9259)
- Meiko Morita (ORCID: https://orcid.org/0009-0000-9248-4265)
- Keita Miura (ORCID: https://orcid.org/0000-0003-2685-5616)
- Haruyasu Murakami (ORCID: https://orcid.org/0000-0003-2416-546X)
- Yuko Iida (ORCID: https://orcid.org/0000-0002-1807-7781)
- Kazushige Wakuda (ORCID: https://orcid.org/0000-0002-6369-2388)
- Haruki Kobayashi (ORCID: https://orcid.org/0000-0002-3386-8063)
- Mitsuhiro Isaka (ORCID: https://orcid.org/0000-0002-6001-7862)
- Nobuaki Mamesaya
- Noboru Morikawa
- Hiroaki Kodama (ORCID: https://orcid.org/0000-0002-0953-3183)
- Kosei Doshita (ORCID: https://orcid.org/0000-0002-0475-573X)
Institutions
- Shizuoka Cancer Center (JP)
Publication Details
- Journal
- Cancer Reports
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cnr2.70004
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00